 |
 |

Biracial Population Study of Mortality in Mild Cognitive Impairment and Alzheimer Disease
Robert S. Wilson, PhD;
Neelum T. Aggarwal, MD;
Lisa L. Barnes, PhD;
Julia L. Bienias, ScD;
Carlos F. Mendes de Leon, PhD;
Denis A. Evans, MD
Arch Neurol. 2009;66(6):767-772. doi:10.1001/archneurol.2009.80
Objective To assess mortality associated with mild cognitive impairment (MCI) and Alzheimer disease (AD) among older African Americans and whites from an urban community.
Design Longitudinal population-based observational study.
Setting Four adjacent neighborhoods in Chicago, Illinois.
Participants Persons deemed free of dementia in a previous wave of data collection (n = 1715) underwent detailed clinical evaluation: 802 had no cognitive impairment (46.8%), 597 had MCI (34.8%), 296 had AD (17.3%), and 20 had other forms of dementia (1.2%).
Main Outcome Measure All-cause mortality.
Results During as many as 10 years of observation (mean [SD], 4.7 [3.0] years), 634 individuals died (37.0%). Compared with people without cognitive impairment, risk of death was increased by about 50% among those with MCI (hazard ratio [95% confidence interval], 1.48 [1.22-1.80]) and was nearly 3-fold greater among those with AD (2.84 [2.29-3.52]). These effects were seen among African Americans and whites and did not differ by race. Among participants with MCI, risk of death increased with more severe cognitive impairment, and this effect did not vary by race. A similar effect was seen among participants with AD, but it was slightly stronger for African Americans vs whites. In the MCI and AD groups, the association of cognitive impairment with survival was stronger for perceptual speed than for other cognitive functions.
Conclusion The presence and severity of MCI and AD are associated with reduced survival among African Americans, and these effects are comparable to those seen among whites.
Author Affiliations: Rush Alzheimer's Disease Center (Drs Wilson, Aggarwal, and Barnes), Rush Institute for Healthy Aging (Drs Bienias, Mendes de Leon, and Evans), and Departments of Neurological Sciences (Drs Wilson, Aggarwal, Barnes, and Evans), Behavioral Sciences (Drs Wilson and Barnes), and Internal Medicine (Drs Bienias, Mendes de Leon, and Evans), Rush University Medical Center, Chicago, Illinois.
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
RELATED ARTICLE
This Month in Archives of Neurology
Arch Neurol. 2009;66(6):689-690.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Vitamin B12, cognition, and brain MRI measures: A cross-sectional examination
Tangney et al.
Neurology 2011;77:1276-1282.
ABSTRACT
| FULL TEXT
Cognitive Impairment: An Independent Predictor of Excess Mortality: A Cohort Study
Sachs et al.
ANN INTERN MED 2011;155:300-308.
ABSTRACT
| FULL TEXT
Cognitive Decline in Prodromal Alzheimer Disease and Mild Cognitive Impairment
Wilson et al.
Arch Neurol 2011;68:351-356.
ABSTRACT
| FULL TEXT
Cognitive activity and the cognitive morbidity of Alzheimer disease
Wilson et al.
Neurology 2010;75:990-996.
ABSTRACT
| FULL TEXT
Temporal course of depressive symptoms during the development of Alzheimer disease
Wilson et al.
Neurology 2010;75:21-26.
ABSTRACT
| FULL TEXT
The Association of Magnetic Resonance Imaging Measures With Cognitive Function in a Biracial Population Sample
Aggarwal et al.
Arch Neurol 2010;67:475-482.
ABSTRACT
| FULL TEXT
Cognitive decline in incident Alzheimer disease in a community population
Wilson et al.
Neurology 2010;74:951-955.
ABSTRACT
| FULL TEXT
|